FDA still reviewing cefepime safety risk
Wednesday, May 14, 2008 - 12:35
in Health & Medicine
WASHINGTON, May 14 (UPI) -- The U.S. Food and Drug Administration said it has not completed a review of safety data concerning increased mortality in patients being treated with cefepime.